Silverberg, J. I.; Cork, M.; Wollenberg, A.; Katoh, N.; Steffensen, L. A.; Kurbasic, A.; Olsen, C. K.; Kuznetsova, A.; ?sterdal, M. L.; Vilsb?ll, A. W.; Deleuran, M. Early Changes in Patient-Relevant Endpoints in Three Tralokinumab Pivotal Phase 3 Trials (ECZTRA 1−3) in Adult Patients With Moderate-to-Severe Atopic Dermatitis. J of Skin 2020, 4, s98.